Skip to main content
. 2021 Apr 17;224(4):620ā€“631. doi: 10.1093/infdis/jiab212

Figure 2.

Figure 2.

Comparison of overall survival and non-relapse mortality amongst all patients with CMV viremia by day 100 post-HCT (nā€…=ā€…375) between CMV controllers and non-controllers. A, Kaplan-Meier curves for overall survival at 1 year by CMV controller status. B, Cumulative incidence curves for non-relapse mortality at 1 year by CMV controller status. Abbreviations: CI, confidence interval; CMV, cytomegalovirus; HCT, hematopoietic cell transplant; HR, hazard ratio.